Guido Oelkers
Guido Oelkers
Chief Executive Officer

Born 1965. Employed since 2017. PhD in Strategic Management, University of South Australia, Master of Economics, South Bank University, London, Complementary studies in Economics, London School of Economics and Political Science.

Other appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.

Previous positions: CEO BSN Medical, President & CEO Gambro, EVP Commercial Operations Nycomed, CEO Invida, Global Head of Healthcare DKSH, previous managerial roles at Aventis and preceding entities, member of the Board of Directors at Meda and Sartories AG.

Henrik Stenqvist
Henrik Stenqvist
Chief Financial Officer

Born 1967. Employed since 2018. Degree in Finance and Business Administration from the University of Linköping, Sweden.

Previous positions:  CFO Recipharm 2017-2018, CFO Meda, 2003-2017, CFO Pharmalink, 2001-2003, Regional Finance Director Astra Zeneca 1999-2000, Finance Director Astra Export&Trading, 1998-1999, Financial Manager, Astra Hungary, 1993-1997.

Torbjörn Hallberg
Torbjörn Hallberg
General Counsel and Head of Legal Affairs

Born 1969 . Employed since 2018. Master of Laws from the University of Lund, Sweden.

Previous positions: Vice President, General Counsel, Emerging Markets at Takeda Pharmaceuticals 2015 - 2017. Senior Director and Senior Corporate Counsel, Takeda Pharmaceuticals, 2011-2015, Corporate Councel, Nycomed Pharma, 2004-2010, Corporate Councel, Ferring Pharmaceuticals, 2001-2004, Senior Associate/Lawer at Advokatfirman Lindahl, 1997-2001.

Christian Dreger
Christian Dreger
Head of Northern Europe, Middle East & Russia

Born 1971. Employed since 2019. MBA and a Ph D from the University of Mannheim in Germany and St. Gallen, Switzerland, Executive MBA from Northwestern University's Kellogg Graduate School of Management. LLB from the University of Hagen in Germany

Previous positions: SVP PAREXEL Consulting and Access PAREXEL, VP Head of Global Commercial Operations Biosimilars Biogen, Regional VP Europe Cubist, Commercial and Managerial roles at AstraZeneca, Managerial roles at Schering-Plough Research Institute, Commercial roles at Roche, Consultant with McKinsey.

 

Sofiane Fahmy
Sofiane Fahmy
Head of Southern and Western Europe & North Africa

Born 1972. Employed since 2013. Degree in Marketing, University of Paris XI France, Degree in Pharmacy University of Poitiers, France

Previous positions: General Manager Sobi France and North Africa, Managerial roles at Pfizer, Commercial roles at GSK, Brand Manager Hospital Products Roche.

Anne-Marie de Jonge
Anne Marie de Jonge Schuermans
Head of Technical Operations

Born: 1972. Employed since 2018. PhD from Swiss Federal Institute of Technology Zurich (ETHZ); M.Sc. degrees in Agriculture & Natural Environment from Wageningen Agricultural University in the Netherlands and in Environmental Management & Technology from the Ecole Polytechnique Féderale Lausanne (EPFL) in Switzerland.

Previous positions: Biogen, Vice President for Global Supply Chain Operations & Strategic Partnerships, and Executive Board Member of Biogen International GmbH; more than 15 years of experience in the healthcare industry from Biogen, Stryker and Novartis, where she headed international functions including Supply Chain Operations, Internal & External Manufacturing, Quality, EHS (Environment, Health & Safety) and Healthcare Compliance. 

Norbert Oppitz
Norbert Oppitz
Head of Specialty Care

Born 1967. Employed since 2017. Dipl. BW (FH)/Business Administrator, FH Rhenania Palatina/Mainz, Germany

Previous positions: Member of the Executive Committee of BSN Medical in charge of Latin America. Member of the Executive Committee of Endo Pharmaceuticals, Emerging Markets. Head of Latin America, Takeda/Nycomed as well as country management roles at Roche Pharmaceuticals and Aventis Pharma.

Amy Pott
Amy Pott
Head of North America

Born: 1976. Employed since 2019. Master of Science, European Policy & Intl Relations, London School of Economics & BA (Hons), History, University of Bristol.

Previous positions: Group Vice President, US Franchise Head Internal Medicine & Oncology as well as Head of Commericial Operations at Shire. Vice President, Global Market Access, & Vice President, Strategy, Planning & Analytics at Baxalta, Several Managerial roles at Baxter Healthcare.

Armin Reininger
Armin Reininger
Head of Medical and Scientific Affairs

Born 1957. Employed since 2017.  MD, PhD , Ludwig-Maximilians-University Munich, Germany; certified specialist in Transfusion Medicine

Previous positions: Baxter Head of Medical Affairs EMEA Hemophilia, Baxalta Head of Global Medical Affairs Hematology, Baxalta/Shire Head of Medical Affairs EMEA Hematology, Senior Physician University Clinic Munich, Dpt. of Transfusion Medicine and Haemostaseology. Visiting Scientist-Visiting Lecturer Harvard Medical School, Mass. General Hospital, Boston, MA, Visiting Fellow The Scripps Research Institute, La Jolla, CA, Professor of Anatomy at the Ludwig Maximilians-University Munich, Germany.

Paula Treutiger
Paula Treutiger
Head of Communications & Investor Relations

Born 1967. Employed since 2019. Degree in Finance and Business Administration, Stockholm University.

Previous positions:  Director Corporate Communications & Investor Relations Medicover, Corporate Communications, IR and Sustainability Meda, Portfolio Manager Swedbank, VP Corporate Communications Gambro, Financial Analyst Carnegie and Alfred Berg.

Fredrik Wetterlund
Fredrik Wetterlundh
Head of Human Resources

Born 1966. Employed since 2018. Holds a degree in HR Management from the University of Lund, Sweden.

Previous positions: Global Human Resources Lead at Pfizer. Senior HR roles in Astra Zeneca, Kraft Foods as well as Codan Group.

Philip Wood
Philip Wood
Head of Haemophilia

Born 1968. Employed since 2012

BSc Joint Honours degree in Geology and Physical Geography, Charted Institute of Marketing certification.

Previous appointments: Head of European Strategic Asset team, Haemophilia, and Business Unit Head Haemophilia, UK, Pfizer.

Milan Zdravkovic
Milan Zdravkovic
Head of Research & Development, Chief Medical Officer

Born: 1970. Employed since: 2016 MD, PhD University of Aarhus, Denmark, MSc Pharmaceutical Medicine, University of Surrey, United Kingdom

Other appointments: DIA Advisory Council Europe, Middle East and Africa. Board member and co-founder of Selma Diagnostics Aps

Previous positions: Corporate Vice President, Novo Nordisk. 18 year tenure in the Research and Development organisation at Novo Nordisk responsible for therapeutic areas including diabetes, devices, growth hormone deficiency, obesity and immunology. Experience from early stage drug development to post-approval life-cycle management.